Acquiring Company
ResMed
Acquired Company
Noctrix Health
United StatesPleasantonMobileHealth CareSportsMedical DeviceBiotechnologyHealth CareMedicalMedical DeviceDescription
On June 3, 2026, ResMed acquired Noctrix Health for a transaction valued at $340 million. This acquisition strengthens ResMed's presence in sleep health and respiratory care by integrating Noctrix's innovative technology into its ecosystem. Noctrix, known for its FDA-authorized therapy for Restless Legs Syndrome, exemplifies disruptive healthcare innovation.
Who to call at ResMed, and when
When ResMed changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ResMed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ResMed, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ResMed makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Noctrix Health?
Noctrix Health was acquired by ResMed, based in United States. The deal was reported on June 4, 2026. At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. ResMed is publicly traded (RMD) and operates in Mobile.
When did ResMed acquire Noctrix Health?
ResMed's acquisition of Noctrix Health was reported on June 4, 2026. On June 3, 2026, ResMed acquired Noctrix Health for a transaction valued at $340 million. This acquisition strengthens ResMed's presence in sleep health and respiratory care by integrating Noctrix's innovative technology into its ecosystem. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Noctrix Health do?
Noctrix Health is a medical device company committed to developing clinically validated breakthrough medical technologies that improve the quality of life for patients with chronic conditions. It is privately held, operating in Biotechnology, and is based in Pleasanton.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.